The potential for biocide tolerance in Escherichia coli and its impact on the response to food processing stresses

Food Control

Volumn 26, Issue 1, 2012, Pages 98-106

  Sheridan, A ^a,b   Lenahan, M ^a   Duffy, G ^a   Fanning, S ^b   Burgess, C ^a  

^a TEAGASC FOOD RESEARCH CENTRE   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Antibiotic resistance; Benzalkonium chloride; Biocide resistance; Triclosan; Verocytotoxigenic E. coli (VTEC)

Indexed keywords

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 84856281106     PISSN: 09567135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodcont.2012.01.018     Document Type: Article

References (45)

1. Autio-Gold J. The role of chlorhexidine in caries prevention. Operative Dentistry 2008, 33:710-716.
2. Besser R.E., Lett S.M., Weber J.T., Doyle M.P., Barrett T.J., Wells J.G., et al. An outbreak of diarrhoea and haemolytic uremic syndrome from Escherichia coli O157:H7 in fresh pressed apple cider. Journal of Applied Microbiology 1993, 269:2217-2220.
3. Bettelheim K.A., Hornitzky M.A., Djordjevic S.P., Kuzevski A. Antibiotic resistance among verocytotoxigenic E. coli (VTEC) and non VTEC isolated from domestic animals and humans. Journal of Medical Microbiology 2003, 52:155-162.
4. Bore E., Hebraud M., Chafsey I., Chambon C., Skjaeret C., Moen B., et al. Adapted tolerance to benzalkonium chloride in Escherichia coli K-12 studied by transcriptome and proteome analyses. Journal of Microbiology 2007, 153:935-946.
5. Braoudaki M., Hilton A.C. Low level of cross- resistance between triclosan and antibiotics in Escherichia coli K-12 and E. coli O55. FEMS Microbiology Letters 2004, 235:305-309.
6. Braoudaki M., Hilton A.C. Adaptive resistance in Salmonella enterica and Escherichia coli O157 and cross-resistance to antimicrobial agents. Journal of Clinical Microbiology 2004, 42:73-78.
7. Champlin F.R., Ellison M.L., Bullard J.W., Conrad R.S. Effect of outer membrane permeabilisation on intrinsic resistance to low triclosan levels in Pseudomonas aeruginosa. Journal of Antimicrobial Agents 2005, 26:159-164.
8. Cheng H.Y., Yu R.C., Chou C.C. Increased acid tolerance of Escherichia coli O157:H7 as affected by acid adaptation time and conditions of acid challenge. Food Research International 2003, 36:49-56.
9. Clinical and Laboratory Standards Institute (CLSI). (2008). Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; approved standard (3rd ed.), Vol. 28, no. 8.
10. Denyer S.P., Maillard J.-Y. Cellular impermeability and uptake of biocides and antibiotics in Gram-negative bacteria. Journal of Applied Microbiology 2002, 92:35-42.
11. Dundas S., Todd W.T. Clinical presentation complications and treatment of infection with verocytotoxin-producing Escherichia coli, challenges for the clinician. Society for Applied Microbiology 2000, 29:24s-30s.
12. European Centre for Disease Prevention & Control (ECDC) Shiga toxin-producing E. coli (STEC): update on outbreak in the EU http://ecdc.europa.eu/en/activitie.
13. Fitzgerald A.C., Edrington T.S., Looper M.L., Callaway T.R., Genovese K.L., Bischoff K.M., et al. Antimicrobial susceptibility and factors effecting the shedding of E. coli O157:H7 and Salmonella in dairy cattle. Letters in Applied Microbiology 2003, 37:392-398.
14. Galland J.C., Hyatt D.R., Crupper S.S., Acheson D.W. Prevalence of antibiotic susceptibility and diversity of E. coli O157:H7 isolates from a longitudinal study of beef cattle feedlots. Applied and Environmental Microbiology 2001, 67:1619-1627.
15. Heathman L.S., Pierce G.O., Kabler K. Resistance of various strains of E. typhi and coli aerogenes to chlorine and chloramine. Public Health Reports 1936, 51:1367-1387.
16. Hegstad K., Langsrud S., Lunestad B.T., Scheie A.A., Sunde M., Yazdankhah S.P. Does the wide use of quaternary ammonium compounds enhance the selection and spread of antimicrobial resistance and thus threaten our health?. Microbial Drug Resistant 2010, 16:91-104.
17. Holah J.T., Taylor J.H., Dawson D.J., Hall K.E. Biocide use in the food industry and the disinfectant resistance of persistent strains of Listeria monocytogenes and Escherichia coli. Journal of Applied Microbiology Symposium Supplement 2002, 92:111s-120s.
18. Institute of Food Technology (IFT) Antimicrobial resistance: implications for the food systems. An expert report, funded by the Institute of Food Technology Foundation. Comprehensive Reviews in Food Science and Food Safety 2006, 185:6883-6892.
19. Jansen W.T., Van der Bruggen J.T., Verhoef J., Fluit A.C. Bacterial resistance; a sensitive issue complexity of the challenge and containment strategy in Europe. Drug Resistance Update 2006, 9:123-133.
20. Jones R.D., Jampani H.B., Newman J.L. Triclosan: a review of effectiveness and safety in health care settings. Antimicrobial Journal of Infection Control 2000, 28:184-196.
21. Karatzas A.G., Webber M.A., Jorgensen F., Woodward M.J., Piddock L.J.V., Humphrey T.J. Prolonged treatment of Salmonella enterica serovar Typhimurium with commercial disinfectants selects for multiple antibiotic resistance, increased efflux and reduced invasiveness. Journal of Antimicrobial Chemotherapy 2007, 60:947-955.
22. Karch H., Bielaszewska M., Bitzan M., Schmidt H. Epidemiology and diagnosis of Shiga toxin-producing Escherichia coli infections. Diagnostic Microbiology and Infectious Disease 1999, 34:229-243.
23. Karmali A. Host and pathogen determinant of verocytotoxin-producing Escherichia coli-associated haemolytic uremic syndrome. Kidney International 2009, 75:4S-7S.
24. Langsrud S., Sundheim G., Holck A.L. Cross-resistance to antibiotics of Escherichia coli adapted to benzalkonium chloride or exposed to stress-inducers. Journal of Applied Microbiology 2004, 96:201-208.
25. Levy S.B. Active efflux mechanisms for antimicrobial resistance. Antimicrobial Agents Chemotherapy 1992, 36:695-703.
26. Levy S.B. Antibiotic and antiseptic resistance: impact on public health. Journal of Paediatric Infectious Diseases 2000, 19:120-122.
27. Levy S.B. Active efflux, a common mechanism for biocide and antibiotic resistance. Journal of Applied Microbiology 2002, 92:65-71.
28. Maillard J.-Y. Bacterial target sites for biocidal action. Journal of Applied Microbiology 2002, 92:16S-27S.
29. McCann M.S., McGovern A.C., McDowell D.A., Blair I.S., Sheridan J.J. Effects of storage and the presence of a beef microflora on the thermal resistance of Salmonella Typhimurium DT104 in beef and broth systems. Journal of Applied Microbiology 2006, 102:1561-1569.
30. McMurry L.M., Oethinger M.M., Levy S.B. Over expression of marA, soxS or acrB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli. FEMS Microbiology Letters 1998, 166:305-309.
31. Mizan S., Lee M.D., Harmon B.G., Tkalcic S., Maurer J.J. Acquisition of antibiotic resistance plasmids by enterohemorrhagic E. coli O157:H7 within rumen fluid. Journal of Food Protection 2002, 65:1038-1040.
32. Panos G.Z., Betsi G.I., Falagas M.E. Systematic review: are antibiotics detrimental or beneficial for the treatment of patients with Escherichia coli O157:H7 infection?. Alimentary Pharmacology & Therapeutics 2006, 24:731-742.
33. O157. Journal of Clinical Microbiology 1998, 36:598-602.
34. Raghubeer E.V., Ke J.S., Campbell M.L., Meyer R.S. Fate of Escherichia coli O157:H7 and other coliforms in commercial mayonnaise and refrigerated salad dressing. Journal of Food Protection 1995, 58:13-18.
35. Ribot E.M., Fair M.A., Gautom R., Cameron D.N., Hunter S.B., Swaminathan B., et al. Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathogens and Disease 2006, 3:59-67.
36. Russell A.D. Mechanisms of bacterial insusceptibility to biocides. American Journal of Infection Control 2001, 29:259-261.
37. Russell A.D. Introduction of biocides into clinical practice and the impact on antibiotic-resistant bacteria. Journal of Applied Microbiology 2002, 92:121-135.
38. Russell A.D. Bacterial adaptation and resistance to antiseptics, disinfectants and preservatives is not a new phenomenon. Journal of Hospital Infection 2004, 57:97-104.
39. Sanchez S., Lee M.D., Harmon B.G., Maurer J.J., Doyle M.P. Animal issues associated with Escherichia coli O157:H7. Journal of the American Veterinary Medical Association 2002, 221:1122-1126.
40. Sivaraman S., Zwahlen J., Bell A.F. Structure activity studies on the inhibition of FabI, the enoyl reductase from Escherichia coli, by triclosan, kinetic analysis of mutant FabIs. Biochemistry 2003, 46:4406-4413.
41. Thomas K.M., McCann M.S., Collery M.M., Logan A., Whyte P., McDowell D.A., et al. Tracking verocytotoxigenic Escherichia coli O157, O26, O111, O103 in Irish cattle. International Journal of Food Microbiology 2011, 10.1016/j.ijfoodmicro.2011.11.012.
42. Walsh S.E., Maillard J.Y., Russell A.D., Catrenich C.E., Charbonneau D.L., Bartolo R.G. Development of bacterial resistance to several biocides and effects on antibiotic susceptibility. Journal of Hospital Infection 2003, 55:98-107.
43. Yu B.J., Kim J.A., Pan J.G. Signature gene expression profile of triclosan-resistant Escherichia coli. Journal of Antimicrobial Chemotherapy 2010, 65:1171-1177.
44. Yuk H., Marshall D.L. Adaptation of Escherichia coli O157:H7 to pH alters membrane lipid composition, verotoxin secretion, and resistance to simulated gastric fluid. Applied and Environmental Microbiology 2004, 70:3500-3505.
45. Zhao T., Doyle M.P. Fate of enterohemorrhagic Escherichia coli O157:H7 in commercial mayonnaise. Journal of Food Protection 1994, 57:780-783.